3-Ethyl-5-phenylpyridine | 81816-92-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-Ethyl-5-phenylpyridine
• CAS: 81816-92-4
• 化学式: C₁₃H₁₃N
• 分子量: 183.253
• InChiKey: DRZOOYMYAOIBLD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  1-phenyl-N-(2-phenylethenyl)methanimine 以 苯 为溶剂， 反应 30.0h， 生成 3-Ethyl-5-phenylpyridine
  参考文献：
  名称：

  Novel synthesis of 3,5-disubstituted pyridines by 1,4-cycloaddition of 1-aza-1,3-butadienes with enamines

  摘要：

  DOI：

  10.1021/jo00189a007

文献信息

• Hepatitis C virus inhibitors
  申请人：D'Andrea Stanley

  公开号：US20070099825A1

  公开（公告）日：2007-05-03

  Macrocyclic peptides are disclosed having the general formula: wherein R′, R 3 , R 3′ , R 4 , R 6 , X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

  大环肽被公开，具有一般的公式： 其中R'，R3，R3'，R4，R6，X，Q和W被描述。还公开了包含该化合物的组合物以及使用该化合物抑制HCV的方法。
• 6-PIPERAZINYL-3,4-DIHYDROQUINAZOLIN-2(1H)-ONES
  申请人：King Abdulaziz City for Science and Technology

  公开号：US20150232448A1

  公开（公告）日：2015-08-20

  A series of new 6-piperazinyl-3,4-dihydroquinazolin-2(1H)-ones have been synthesized. The compounds are structurally related to adoprazine, a potential atypical antipsychotics bearing potent D 2 receptor antagonist and 5-HT 1A receptor agonist properties. Buchwald-Hartwig coupling of suitably modified aryl bromides with tert-butyl piperazine-1-carboxylate afforded the advanced intermediate piperazinyl-3,4-dihydroquinazolin-2(1H)-one. The reductive amination of the latter with appropriately designed biarylaldehydes accomplished the synthesis of these compounds.

  已合成一系列新的6-哌嗪基-3,4-二氢喹唑啉-2(1H)-酮。这些化合物在结构上与阿多普拉辛（adoprazine）相关，后者是一种潜在的非典型抗精神病药物，具有强效的D2受体拮抗剂和5-HT1A受体激动剂性质。通过适当改性的芳基溴化物与叔丁基哌嗪-1-羧酸酯的Buchwald-Hartwig偶联反应，得到了先进的中间体哌嗪基-3,4-二氢喹唑啉-2(1H)-酮。后者与设计合理的双芳基醛进行还原胺化反应，完成了这些化合物的合成。
• 4-ARYL-1-(BIARYLMETHYLENE) PIPERIDINE COMPOUNDS
  申请人：KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY

  公开号：US20140296528A1

  公开（公告）日：2014-10-02

  The 4-aryl-1-(biarylmethylene)piperidine compounds are piperadine compounds having a biaryl substituent linked to the nitrogen atom of the piperidine ring by a methylene (—CH 2 —) group, and an aryl moiety attached to the 4-position of the piperidine ring. The aryl moiety may be a methoxy quinoline group, a 2-oxo quinoline group, or a 2-oxo, 3,4-dihydroxy quinoline group. The biaryl substituent may be biphenyl, fluorophenyl benzene, 3-phenyl pyridine, 3-(4-fluorophenyl) pyridine, phenyl cyclopentene, or 3-(1-cyclopenten-1-yl) pyridine. The compounds are believed to be suitable for anti-psychotic medication, since they are structurally related to SLV-313, a potential atypical antipsychotic having potent D 2 receptor antagonist and 5-HT 1A receptor agonist properties.

  4-芳基-1-(联苯基亚甲基)哌啶化合物是一类哌啶化合物，其具有通过一个亚甲基(—CH2—)基团连接到哌啶环的氮原子的联苯基取代基，并且一个芳基固定在哌啶环的4-位置。芳基可能是一个甲氧基喹啉基团，一个2-氧基喹啉基团，或一个2-氧基，3,4-二羟基喹啉基团。联苯基取代基可能是联苯，氟苯基苯，3-苯基吡啶，3-(4-氟苯基)吡啶，苯基环戊烯，或3-(1-环戊烯-1-基)吡啶。这些化合物被认为适用于抗精神病药物，因为它们在结构上与SLV-313相关，SLV-313是一种潜在的非典型抗精神病药物，具有强效的D2受体拮抗剂和5-HT1A受体激动剂特性。
• Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
  申请人：Cook, II James H.

  公开号：US20100099684A1

  公开（公告）日：2010-04-22

  The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.

  本公开提供公式I的化合物，包括其盐，以及使用这些化合物的组合物和方法。这些化合物是尼古丁α7受体的配体，可能对中枢神经系统的各种疾病，特别是情感和神经退行性疾病的治疗有用。
• Imine Compound
  申请人：Saito Shiuji

  公开号：US20080312435A1

  公开（公告）日：2008-12-18

  An imine compound represented by the formula: wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom(s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents —CO—, —CO—CO—, —CO—NH—, —CS—NH—, or —SO 2 —, or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.

  一种以以下式表示的亚胺化合物：其中A代表杂环基团；R1、R2和R3分别表示氢原子、卤素原子、C1-10烷基，该烷基可选地取代有芳基，所述芳基取代有卤素原子，C3-10环烷基，C1-6卤代烷基，C1-10烷氧基等；R4表示可选地取代的C1-10烷基，C2-6烯基或芳基；R5表示氢原子，C1-10烷氧基，C1-6卤代烷基，可选地取代的C1-10烷基或C2-6烯基，可选地取代的芳基或杂环基团等；W表示—CO—，—CO—CO—，—CO—NH—，—CS—NH—或—SO2—，或以该亚胺化合物为活性成分的大麻素受体激动剂。本发明的亚胺化合物具有大麻素受体激动剂作用，可用作治疗或预防疼痛和自身免疫性疾病的药物。